Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation.
作者信息
Horwich L, Galloway R
出版信息
Br Med J. 1965 Nov 27;2(5473):1274-7. doi: 10.1136/bmj.2.5473.1274.
Abstract
摘要
相似文献
1
Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation.
Br Med J. 1965 Nov 27;2(5473):1274-7. doi: 10.1136/bmj.2.5473.1274.
2
A trial of carbenoxolone sodium in the treatment of gastric ulceration.
S Afr Med J. 1967 Mar 25;41(12):297-300.
3
Gastric ulcer treatment with carbenoxolone sodium ('biogastrone').
N Z Med J. 1966 May;65(405):308-9.
4
Controlled double blind trial of carbenoxolone in gastric and duodenal ulcer.
Int J Clin Pharmacol. 1974 Dec;10(4):309-18.
5
Carbenoxolone sodium in the treatment of gastric ulceration in Chinese.
Med J Aust. 1974 Dec 28;2(26):919-22. doi: 10.5694/j.1326-5377.1974.tb93773.x.
6
A comparison of carbenoxolone sodium and deglycyrrhizinated liquorice in the treatment of gastric ulcer in the ambulant patient.
Br J Clin Pract. 1972 Dec;26(12):563-6.
7
[Carbenoxolone in the treatment of persistent gastric ulcer].
Tidsskr Nor Laegeforen. 1969 Dec 15;89(24):1892-4.
8
Review of carbenoxolone: editorial comment.
Am J Gastroenterol. 1973 Jul;60(1):81-3.
9
[Therapy of gastric ulcer with carbenoxolon sodium. Results of a double-blind study].
Med Klin. 1970 Jan 9;65(2):74-7.
10
[Treatment of gastric and duodenal ulcers using carbenoxolone sodium. (Double blind trial)].
Munch Med Wochenschr. 1972 May 12;114(19):925-9.
引用本文的文献
1
Analgesic and anti-inflammatory properties of carbenoxolone: a review.
Inflammopharmacology. 2025 Sep 28. doi: 10.1007/s10787-025-01937-1.
2
Adverse effects of anti-ulcer drugs.
Drugs. 1981 Jun;21(6):444-59. doi: 10.2165/00003495-198121060-00004.
3
Morphological observations on gastric ulcers treated with carbenoxolone sodium.
Gut. 1967 Dec;8(6):544-7. doi: 10.1136/gut.8.6.544.
4
Side effects of carbenoxolone sodium: a study of ambulant therapy of gastric ulcer.
Gut. 1967 Apr;8(2):148-50. doi: 10.1136/gut.8.2.148.
5
Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone (biogastrone).
Br Med J. 1966 Jun 25;1(5503):1581-2. doi: 10.1136/bmj.1.5503.1581.
6
Biochemical effects of short-term treatment with carbenoxolone disodium.
Br J Pharmacol Chemother. 1966 Feb;26(2):412-20. doi: 10.1111/j.1476-5381.1966.tb01921.x.
7
Peptic ulcer: surgical treatment.
Br Med J. 1969 Oct 11;4(5675):102-5. doi: 10.1136/bmj.4.5675.102.
8
Muscle paresis and hypokalemia after treatment with duogastrone.
Br Med J. 1969 Jun 14;2(5658):674. doi: 10.1136/bmj.2.5658.674.
9
The medical treatment of gastric and duodenal ulcer.
Postgrad Med J. 1968 Aug;44(514):603-7. doi: 10.1136/pgmj.44.514.603.
10
Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone.
Gut. 1968 Feb;9(1):42-5. doi: 10.1136/gut.9.1.42.
本文引用的文献
1
Peptic ulcer cases reviewed after 10 years; effect of medical treatment and indications for gastrectomy.
Lancet. 1949 Dec 17;2(6590):1115-20. doi: 10.1016/s0140-6736(49)91143-5.
2
Factors influencing the rate of healing of gastric ulcers; admission to hospital, phenobarbitone, and ascorbic acid.
Lancet. 1952 Jan 26;1(6700):171-5. doi: 10.1016/s0140-6736(52)91405-0.
3
Ineffectiveness of chicken antiulcer factors in treatment of gastric and duodenal ulcer in man.
Br Med J. 1955 Apr 2;1(4917):818-20. doi: 10.1136/bmj.1.4917.818.
4
GASTRIC ULCERS, BLOOD GROUPS, AND ACID SECRETION.
Gut. 1964 Oct;5(5):402-11. doi: 10.1136/gut.5.5.402.
5
Effect of smoking on the production and maintenance of gastric and duodenal ulcers.
Lancet. 1958 Mar 29;1(7022):657-62. doi: 10.1016/s0140-6736(58)91083-3.
6
Chronic gastric ulcer; a comparison between a gastroscopically controlled series treated medically and a series treated by surgery.
Br Med J. 1953 Oct 17;2(4841):841-7. doi: 10.1136/bmj.2.4841.841.
Zotero 插件